FDA Clears New Alzheimer’s Blood Test

Topline

The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to help identify symptoms related to Alzheimer’s disease in patients over age 55, Roche said on Monday morning.

Key Facts

This is a breaking story and will be updated.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top